| URL | https://www.fiercepharma.com/pharma/sanofi-hops-us |
| Source | Fierce Pharma |
| Date Published | 05/14/2025 |
| Author Name | Kevin Dunleavy |
| Company/Division name | Sanofi |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2030 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 20,000 |
| Country(ies) from which reshored: | France |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |